Paper Diagnostics Market Report
The report on the Global Paper Diagnostics Market is segmented By Product (Lateral Flow Assays, Dipsticks, Paper Based Microfluidics), Device Type (Diagnostic Devices, Monitoring Devices), Application (Clinical Diagnostics, Food Quality Testing, Environmental Monitoring), End-User (Home Healthcare, Assisted Living Healthcare Facilities, Hospital and Clinics) and Region - COVID-19 Impact Analysis and Forecast to 2026.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global Paper Diagnostics market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
The report on the Global Paper Diagnostics Market is segmented By Product (Lateral Flow Assays, Dipsticks, Paper Based Microfluidics), Device Type (Diagnostic Devices, Monitoring Devices), Application (Clinical Diagnostics, Food Quality Testing, Environmental Monitoring), End-User ...
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
The Global Paper Diagnostics Market is expected to grow from USD 7.2 billion in 2020 to USD 11.0 billion by 2026 at a CAGR of over 7.5% during the forecast period.
Figure: Global Paper Diagnostics Market Size, 2020-2026 (USD Billion)
To know about the assumptions related to the report, Request for Free Sample here.
Paper diagnostics are defined as devices that are made of paper or cellulosic materials to recognize and quantify chemical agents and biomolecules which affect health. Paper diagnostic products include lateral flow assays, dipsticks, and paper-based microfluidics.
Lateral flow assays are one of the most commonly used product types in various applications including pregnancy tests and diseases such as TB & HIV.
Key players operating in the global Paper Diagnostics Market are-
The growth of the global paper diagnostics market is primarily driven by a surge in demand for cost-effective diagnostic methods.
Based on application, the market has been segmented into clinical diagnostics, food quality testing and environmental monitoring.
Geographically, the market in North America accounted for the largest market share in 2020 owing to the presence of a strong healthcare industry coupled with high demand for advanced diagnostic solutions.
The market in Asia-Pacific is expected to register the fastest growth during the review period on account of rising product awareness coupled with the prevalence of a high number of people suffering from TB and dengue.
The covid-19 outbreak impacted the growth of paper diagnostics positively. The demand for rapid testing diagnostics increased significantly with a spike in covid-19 cases across geographies. The coronavirus outbreak has taken a massive toll on individuals, communities, families, and societies around the world.
Wish to get a customised report? Click here.
The following is a list of the customers that the Paper Diagnostics market aims to convert the most:
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].
The paper diagnostics market is expected to witness an impressive growth of 7.5% CAGR in the foreseeable future.
ARKRAY, INC. (Japan), ACON LABORATORIES, INC. (The U.S), GVS S.P.A. (Italy), Bio-Rad Laboratories, Inc. (The U.S), Abbott Laboratories (The U.S), Siemens Healthineers AG (Germany), Diagnostics For All Inc (The U.S), Navigene, Genetic Science Private (India), Kenosha C.V. (Netherlands) and Micro Essential Laboratory Inc (The U.S) are among the key players in the paper diagnostics market.
The paper diagnostics market size is expected to reach USD 11.0 billion in the coming years.
North America accounted for the largest share of paper diagnostics market in 2020.
Asia-pacific is expected to register the fastest growth in the paper diagnostics market in the coming years.
Surge in demand for cost-effective diagnostic methods, wide availability and superior properties of paper such as cost-effectiveness, biocompatible, biodegradable, and combustible are the factors driving the growth of paper diagnostics market.
Paper diagnostics manufacturers, Paper diagnostics suppliers, Paper diagnostics distributors, Organizations, Government bodies are the target audience in the paper diagnostics market.